Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-06-01 | Mr. John Adam ZangerleSenior VP, General Counsel & Secretary | -337,00 | 0,00 | Sale to Issuer | - | 33,33k | -1,00% |
| 2026-06-01 | Mr. Renato G. TamaroVP & Corporate Treasurer | -81,00 | 0,00 | Sale to Issuer | - | 5,61k | -1,42% |
| 2026-06-01 | Ms. Lindsey McGowanVP, Chief Compliance & Quality Officer | -198,00 | 0,00 | Sale to Issuer | - | 5,09k | -3,75% |
| 2026-06-01 | Ms. Julia K. MadsenSenior VP & GM of Life Sciences | -208,00 | 0,00 | Sale to Issuer | - | 10,50k | -1,94% |
| 2026-06-01 | Mr. Cary L. MajorsSenior VP & President of Healthcare | -768,00 | 0,00 | Sale to Issuer | - | 12,73k | -5,69% |
| 2026-06-01 | Mr. Kenneth E. KohlerSenior VP & GM of AST | -109,00 | 0,00 | Sale to Issuer | - | 9,53k | -1,13% |
| 2026-06-01 | Ms. Mary Clare FraserSVP & Chief HR Officer | -673,00 | 0,00 | Sale to Issuer | - | 12,21k | -5,22% |
| 2026-06-01 | Mr. Daniel A. CarestioPresident, CEO & Director | -1,25k | 0,00 | Sale to Issuer | - | 49,84k | -2,45% |
| 2026-06-01 | Ms. Karen L. BurtonSenior VP, CFO & CAO | -99,00 | 0,00 | Sale to Issuer | - | 8,21k | -1,19% |
| 2026-03-05 | Ms. Cynthia L. FeldmannIndependent Director | -3,10k | 262,99k | Derivative Exercise and Sale | 152,32 - 237,21 | 9,37k | - |
| 2025-11-21 | Ms. Julia K. MadsenSenior VP & GM of Life Sciences | -5,01k | 669,96k | Derivative Exercise and Sale | 114,22 - 262,00 | 10,71k | - |
| 2025-11-18 | Mr. Renato G. TamaroVP & Corporate Treasurer | -3,54k | 266,07k | Derivative Exercise and Sale | 182,22 - 258,03 | 5,70k | - |
| 2025-11-18 | Mr. Renato G. TamaroVP & Corporate Treasurer | -1,50k | 386,64k | Verkauf | 257,76 | 5,70k | -20,85% |
| 2025-11-11 | Mr. John Adam ZangerleSenior VP, General Counsel & Secretary | -15,00k | 2,93M | Derivative Exercise and Sale | 69,72 - 265,14 | 33,67k | - |
| 2025-10-06 | Mr. Daniel A. CarestioPresident, CEO & Director | -159,00 | 38,45k | Verkauf | 241,82 | 51,10k | -0,31% |
| 2025-10-01 | Mr. Renato G. TamaroVP & Corporate Treasurer | -26,00 | 0,00 | Sale to Issuer | - | 7,20k | -0,36% |
| 2025-10-01 | Mr. John Adam ZangerleSenior VP, General Counsel & Secretary | -91,00 | 0,00 | Sale to Issuer | - | 33,67k | -0,27% |
| 2025-10-01 | Mr. Cary L. MajorsSenior VP & President of Healthcare | -303,00 | 0,00 | Sale to Issuer | - | 13,49k | -2,20% |
| 2025-10-01 | Ms. Mary Clare FraserSVP & Chief HR Officer | -207,00 | 0,00 | Sale to Issuer | - | 12,88k | -1,58% |
| 2025-10-01 | Ms. Julia K. MadsenSenior VP & GM of Life Sciences | -52,00 | 0,00 | Sale to Issuer | - | 10,71k | -0,48% |
| 2025-10-01 | Ms. Karen L. BurtonSenior VP, CFO & CAO | -39,00 | 0,00 | Sale to Issuer | - | 8,30k | -0,47% |
| 2025-10-01 | Mr. Daniel A. CarestioPresident, CEO & Director | -130,00 | 0,00 | Sale to Issuer | - | 51,26k | -0,25% |
| 2025-08-20 | Mr. Renato G. TamaroVP & Corporate Treasurer | -3,20k | 327,42k | Derivative Exercise and Sale | 147,05 - 249,24 | 7,22k | - |
| 2025-08-13 | Mr. Richard Carroll BreedenIndependent Director | 4,11k | 263,25k | Derivative Exercise and Retained Stock | 64,05 | 36,66k | 12,63% |
| 2025-08-11 | Dr. Mohsen M. SohiIndependent Chairman of the Board | -4,11k | 731,21k | Derivative Exercise and Sale | 64,05 - 241,96 | 22,36k | - |
| 2025-08-11 | Ms. Cynthia L. FeldmannIndependent Director | -3,50k | 844,25k | Derivative Exercise and Sale | 241,56 | 9,37k | - |
| 2025-08-11 | Ms. Karen L. BurtonSenior VP, CFO & CAO | -7,90k | 1,01M | Derivative Exercise and Sale | 114,22 - 241,73 | 5,99k | - |
| 2025-06-13 | Mr. John Adam ZangerleSenior VP, General Counsel & Secretary | -1,98k | 477,58k | Verkauf | 240,63 - 241,61 | 33,76k | -5,53% |
| 2025-06-04 | Mr. Michael J. TokichInsider | -341,00 | 82,56k | Sale to Issuer | 242,10 | 47,48k | -0,71% |
| 2025-06-04 | Ms. Julia K. MadsenSenior VP & GM of Life Sciences | -194,00 | 46,97k | Sale to Issuer | 242,10 | 10,76k | -1,77% |
| 2025-06-04 | Mr. John Adam ZangerleSenior VP, General Counsel & Secretary | -425,00 | 102,89k | Sale to Issuer | 242,10 | 35,74k | -1,18% |
| 2025-06-05 | Mr. Daniel A. CarestioPresident, CEO & Director | -17,63k | 4,28M | Verkauf | 241,85 - 243,49 | 51,39k | -25,54% |
| 2025-06-04 | Mr. Daniel A. CarestioPresident, CEO & Director | -1,92k | 465,07k | Sale to Issuer | 242,10 | 51,39k | -3,60% |
| 2025-06-04 | Mr. Kenneth E. KohlerSenior VP & GM of AST | -154,00 | 37,28k | Sale to Issuer | 242,10 | 6,78k | -2,22% |
| 2025-06-04 | Ms. Karen L. BurtonSenior VP, CFO & CAO | -92,00 | 22,27k | Sale to Issuer | 242,10 | 5,99k | -1,51% |
| 2025-06-04 | Mr. Renato G. TamaroVP & Corporate Treasurer | -66,00 | 15,98k | Sale to Issuer | 242,10 | 7,22k | -0,91% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
